Skip to content

SIMDA

Active
Private limited companyfounded 2021active for 5 yearsDoornstraat 20, 1700 Dilbeek, BelgiumKBO/BCE: BE 0769.312.344
Summary

SIMDA has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2,000 and a net result of €289,573. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 20,335 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Medical imaging and medical laboratories
NACE 86910
1 site
Size
€770,508total assets 2025
Equity
€2,000
Profit
€289,573
Turnover not published (micro format)
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 19 days early0 of 2 deeds read
Why 91raises riskEquity €2,000 (0.3% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €770,508Liquidity: current ratio 0.98, cash €716,572Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 26% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Average
Solvency 25-75
equity 0.3% of total assets
Liquidity 50-47
short-term debt 99.7% · cash 93.0%
Profitability 100=
return on assets 37.6%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,040 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 4% on solvency, 20% on liquidity, 80% on profitability and 2% on growth.

The bankruptcy probability was computed on 13-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €770,508
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €2,000 (0.3% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.98, cash €716,572
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20335 sector peers (2025).
NBB · sector comparison
Position among 20335 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-07-2026, 19 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
19 days early
2024
1 day early
2023
31 days late
2022
26 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 4 accounts on average 9 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 13 August (3 of the last 4 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
14-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Highest result from 2022 to 2025net €289,573 ▲37%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

Equity
€2,000▼ 99.6%
2024 · €457,237
Total assets
€770,508▲ 43.4%
2024 · €537,423
Net result
€289,573▲ 37.0%
2024 · €211,419
Working capital
-€11,624
2024 · €431,626
Trend over the years

2022 to 2025, 4 financial years

After the dip in 2023 the operating result has climbed two years in a row; 2025 is 33% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€384,946 2025 Net result€289,573 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line2022202320242025
Operating result€157,590-€143,601▼ 8.9%€289,980▲ 102%€384,946▲ 32.7%
Net result€124,832above the sector's middle half-€118,986above the sector's middle half▼ 4.7%€211,419above the sector's middle half▲ 77.7%€289,573above the sector's middle half▲ 37.0%
Equity€126,832within the sector's middle half-€245,818within the sector's middle half▲ 93.8%€457,237above the sector's middle half▲ 86.0%€2,000below the sector's middle half▼ 99.6%
Total assets€204,858within the sector's middle half-€316,205within the sector's middle half▲ 54.4%€537,423within the sector's middle half▲ 70.0%€770,508above the sector's middle half▲ 43.4%
Debt€78,026-€70,387▼ 9.8%€80,186▲ 13.9%€768,508▲ 858%
Working capital€80,905within the sector's middle half-€209,300within the sector's middle half▲ 159%€431,626above the sector's middle half▲ 106%-€11,624below the sector's middle half
Solvency61.9%within the sector's middle half-77.7%within the sector's middle half▲ 15.8pp85.1%within the sector's middle half▲ 7.3pp0.3%below the sector's middle half▼ 84.8pp
Current ratio2.04within the sector's middle half-3.97within the sector's middle half▲ 1.946.38within the sector's middle half▲ 2.410.98below the sector's middle half▼ 5.40
Return on assets (ROA)60.9%above the sector's middle half-37.6%above the sector's middle half▼ 23.3pp39.3%above the sector's middle half▲ 1.7pp37.6%within the sector's middle half▼ 1.8pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €770,508
Fixed assets €13,624 ▼ 46.8%
Current assets €756,884 ▲ 47.9%
Equity and liabilities €770,508
Equity €2,000 ▼ 99.6%
Debt €768,508 ▲ 858%
Debt's share of the balance-sheet total rises from 14.9% to 99.7%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€398,414▲
2024 · €303,944
Cash flow
€303,040▲
2024 · €225,383
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€768,508▲
2024 · €80,186
Income taxes
€95,238▲
2024 · €78,487
Staff costs
€38,510▲
2024 · €27,906
A ratio outside any meaningful range has been withheld (balance sheet total €770,508, equity €2,000).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 875 companies that looked in July 2024 the way this one looks now, 1.4% went bankrupt within 24 months and 96.6% are still going.

  • Small
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
1.4% went bankrupt
1.9% stopped otherwise
96.6% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,470 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 875 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet Code20242025
Assets
Total assets20/58€537,423€770,508▲
Fixed assets21/28€25,611€13,624▼
Tangible fixed assets22/27€25,611€13,624▼
Plant, machinery and equipment23€23,578€11,793▼
Furniture and vehicles24€2,033€1,830▼
Current assets29/58€511,812€756,884▲
Amounts receivable within one year40/41€27-
Trade receivables40€27-
Cash at bank and in hand54/58€511,627€716,572▲
Deferred charges and accrued income490/1€158€40,312▲
Equity and liabilities
Total equity and liabilities10/49€537,423€770,508▲
Equity10/15€457,237€2,000▼
Contributions10/11€2,000€2,000=
Profit (loss) carried forward14€455,237-
Amounts payable17/49€80,186€768,508▲
Amounts payable within one year42/48€80,186€768,508▲
Trade debts44€1,133€1,433▲
Suppliers440/4€1,133€1,433▲
Taxes, remuneration and social security45€76,987€97,472▲
Taxes450/3€70,336€90,574▲
Remuneration and social security454/9€6,651€6,898▲
Other amounts payable47/48€2,066€669,603▲
Income statement Code20242025
Remuneration, social security and pensions62€27,906€38,510▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13,965€13,467▼
Other operating charges640/8€650€1,210▲
Gross operating margin9900€332,501€438,133▲
Operating profit (loss)9901€289,980€384,946▲
Financial income75/76B€1-
Recurring financial income75€1-
Financial charges65/66B€74€135▲
Recurring financial charges65€74€135▲
Profit (loss) for the period before taxes9903€289,906€384,811▲
Income taxes67/77€78,487€95,238▲
Profit (loss) for the period9904€211,419€289,573▲
Profit (loss) for the period to be appropriated9905€211,419€289,573▲
Appropriation of the result
Profit (loss) to be appropriated9906€455,237€744,810▲
Profit (loss) brought forward from the previous period14P€243,818€455,237▲
Profit to be distributed694/7-€744,810
Return on contributions (dividend)694-€744,810

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2022202320242025Change
Goods, raw materials, services and sundry goods60/61-€74,690---
Remuneration, social security and pensions62-€12,445€27,906€38,510▲ 38.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,825€13,159€13,965€13,467▼ 3.6%
Other operating charges640/8€230€434€650€1,210▲ 86.0%
Gross operating margin9900€159,645€169,639€332,501€438,133▲ 31.8%
Operating profit (loss)9901€157,590€143,601€289,980€384,946▲ 32.7%
Financial income75/76B-€3€1--
Recurring financial income75-€3€1--
Financial charges65/66B€110€73€74€135▲ 82.2%
Recurring financial charges65€110€73€74€135▲ 82.2%
Non-recurring financial charges66B€110€73---
Profit (loss) for the period before taxes9903€157,480€143,531€289,906€384,811▲ 32.7%
Income taxes67/77€32,648€24,545€78,487€95,238▲ 21.3%
Profit (loss) for the period9904€124,832€118,986€211,419€289,573▲ 37.0%
Profit (loss) for the period to be appropriated9905€124,832€118,986€211,419€289,573▲ 37.0%
Line2022202320242025Change
Assets
Total assets20/58€204,858€316,205€537,423€770,508▲ 43.4%
Fixed assets21/28€45,927€36,518€25,611€13,624▼ 46.8%
Tangible fixed assets22/27€45,927€36,518€25,611€13,624▼ 46.8%
Plant, machinery and equipment23€45,927€34,439€23,578€11,793▼ 50.0%
Furniture and vehicles24-€2,079€2,033€1,830▼ 10.0%
Current assets29/58€158,931€279,687€511,812€756,884▲ 47.9%
Amounts receivable within one year40/41--€27--
Trade receivables40--€27--
Cash at bank and in hand54/58€158,252€244,397€511,627€716,572▲ 40.1%
Deferred charges and accrued income490/1€678€35,289€158€40,312▲ 25,364%
Equity and liabilities
Total equity and liabilities10/49€204,858€316,205€537,423€770,508▲ 43.4%
Equity10/15€126,832€245,818€457,237€2,000▼ 99.6%
Contributions10/11€2,000€2,000€2,000€2,000=
Profit (loss) carried forward14€124,832€243,818€455,237--
Amounts payable17/49€78,026€70,387€80,186€768,508▲ 858%
Amounts payable within one year42/48€78,026€70,387€80,186€768,508▲ 858%
Trade debts44€32,572€406€1,133€1,433▲ 26.4%
Suppliers440/4€32,572€406€1,133€1,433▲ 26.4%
Taxes, remuneration and social security45€32,648€58,806€76,987€97,472▲ 26.6%
Taxes450/3€32,648€57,193€70,336€90,574▲ 28.8%
Remuneration and social security454/9-€1,613€6,651€6,898▲ 3.7%
Other amounts payable47/48€12,806€11,174€2,066€669,603▲ 32,304%
Line2022202320242025Change
Profit (loss) for the period9904€124,832€118,986€211,419€289,573▲ 37.0%
+ Depreciation and write-downs630€1,825€13,159€13,965€13,467▼ 3.6%
Operating cash flow (approximation)€126,657€132,144€225,383€303,040▲ 34.5%
Investment in fixed assets (approximation)--€3,749-€3,058-€1,480▲ 51.6%
Change in cash-€86,145€267,229€204,946▼ 23.3%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (4)
Financial year Type Filed Reference
31-12-2025 micro format 12-07-2026 2026-00295343
31-12-2024 micro format 30-07-2025 2025-00361855
31-12-2023 micro format 31-08-2024 2024-00421707
31-12-2022 micro format 26-08-2023 2023-00359374

Similar companies · same sector, comparable size

Of the 694 active companies whose main activity is medical imaging and medical laboratories (NACE 86910), figures are known for 524. 39 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

SIMDA was incorporated on 3 June 2021 as a private limited company.1 Total assets rose from €204,858 in 2022 to €770,508 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2022 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
12-07
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Highest result from 2022 to 2025net €289,573 ▲37%
Operating result €384,946, net result €289,573, both a record.
30-07
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-08
NBB filing Annual accounts filed
financial year 2023 · micro format · 31 days late
2023
31-12
Financial Equity above €200,000equity €245,818 ▲93.8%
A profit in every financial year since 2022 builds equity to €245,818.
26-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts

We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded03-06-2021
Financial year end31-12
Activities, NACEBEL 2025
86910Medical imaging and medical laboratories
E-invoicing
Reachable via Peppol
Peppol ID 0208:0769312344
Also 9925:BE0769312344
Registered 27-09-2024

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 14 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Dilbeek · 1 establishment unit since 2021
registered office establishment The establishment unit on the map
Ground area
490 m²
Building footprint
108 m²
Building volume
747 m³
Parcel 23352G0158/00T003, Flanders · tallest building 11.3 m. Linked by address, not a title deed.
1 establishment unit
SIMDA
Doornstraat 20, 1700 DilbeekMedical imaging and medical laboratories
since 2021unit no. 2.318.808.952
1 parcel
Flanders 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
23352G0158/00T003 Flanders 490 m² 1 · 108 m² 11.3 m · 3
How the parcels are linked
Good to know
The parcel matches the address exactly.